Literature DB >> 25422397

Expanding the toolbox in pursuit of a strain transcendent malaria vaccine.

Anne E P Frosch1, Chandy C John2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25422397      PMCID: PMC4347362          DOI: 10.4269/ajtmh.14-0662

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


× No keyword cloud information.
  17 in total

1.  Structural basis of antigenic escape of a malaria vaccine candidate.

Authors:  Sheetij Dutta; Seung Yeon Lee; Adrian H Batchelor; David E Lanar
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-16       Impact factor: 11.205

2.  TLRs innate immunereceptors and Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) CIDR1α-driven human polyclonal B-cell activation.

Authors:  Olivia Simone; Maria Teresa Bejarano; Susan K Pierce; Salvatore Antonaci; Mats Wahlgren; Marita Troye-Blomberg; Daria Donati
Journal:  Acta Trop       Date:  2011-05-19       Impact factor: 3.112

Review 3.  Malaria adhesins: structure and function.

Authors:  Brian M Malpede; Niraj H Tolia
Journal:  Cell Microbiol       Date:  2014-03-06       Impact factor: 3.715

4.  A field trial to assess a blood-stage malaria vaccine.

Authors:  Mahamadou A Thera; Ogobara K Doumbo; Drissa Coulibaly; Matthew B Laurens; Amed Ouattara; Abdoulaye K Kone; Ando B Guindo; Karim Traore; Idrissa Traore; Bourema Kouriba; Dapa A Diallo; Issa Diarra; Modibo Daou; Amagana Dolo; Youssouf Tolo; Mahamadou S Sissoko; Amadou Niangaly; Mady Sissoko; Shannon Takala-Harrison; Kirsten E Lyke; Yukun Wu; William C Blackwelder; Olivier Godeaux; Johan Vekemans; Marie-Claude Dubois; W Ripley Ballou; Joe Cohen; Darby Thompson; Tina Dube; Lorraine Soisson; Carter L Diggs; Brent House; David E Lanar; Sheetij Dutta; D Gray Heppner; Christopher V Plowe
Journal:  N Engl J Med       Date:  2011-09-15       Impact factor: 91.245

5.  Seroreactivity to a large panel of field-derived Plasmodium falciparum apical membrane antigen 1 and merozoite surface protein 1 variants reflects seasonal and lifetime acquired responses to malaria.

Authors:  Jason A Bailey; Jozelyn Pablo; Amadou Niangaly; Mark A Travassos; Amed Ouattara; Drissa Coulibaly; Matthew B Laurens; Shannon L Takala-Harrison; Kirsten E Lyke; Jeff Skinner; Andrea A Berry; Algis Jasinskas; Rie Nakajima-Sasaki; Bourema Kouriba; Mahamadou A Thera; Philip L Felgner; Ogobara K Doumbo; Christopher V Plowe
Journal:  Am J Trop Med Hyg       Date:  2014-10-06       Impact factor: 2.345

Review 6.  How malaria modulates memory: activation and dysregulation of B cells in Plasmodium infection.

Authors:  Anja Scholzen; Robert W Sauerwein
Journal:  Trends Parasitol       Date:  2013-04-04

7.  Extreme polymorphism in a vaccine antigen and risk of clinical malaria: implications for vaccine development.

Authors:  Shannon L Takala; Drissa Coulibaly; Mahamadou A Thera; Adrian H Batchelor; Michael P Cummings; Ananias A Escalante; Amed Ouattara; Karim Traoré; Amadou Niangaly; Abdoulaye A Djimdé; Ogobara K Doumbo; Christopher V Plowe
Journal:  Sci Transl Med       Date:  2009-10-14       Impact factor: 17.956

8.  Overcoming antigenic diversity by enhancing the immunogenicity of conserved epitopes on the malaria vaccine candidate apical membrane antigen-1.

Authors:  Sheetij Dutta; Lisa S Dlugosz; Damien R Drew; Xiaopeng Ge; Xiopeng Ge; Diouf Ababacar; Yazmin I Rovira; J Kathleen Moch; Meng Shi; Carole A Long; Michael Foley; James G Beeson; Robin F Anders; Kazutoyo Miura; J David Haynes; Adrian H Batchelor
Journal:  PLoS Pathog       Date:  2013-12-26       Impact factor: 6.823

9.  Chronic exposure to Plasmodium falciparum is associated with phenotypic evidence of B and T cell exhaustion.

Authors:  Joseph Illingworth; Noah S Butler; Sophie Roetynck; Jedida Mwacharo; Susan K Pierce; Philip Bejon; Peter D Crompton; Kevin Marsh; Francis M Ndungu
Journal:  J Immunol       Date:  2012-12-21       Impact factor: 5.422

10.  Diversity covering AMA1-MSP119 fusion proteins as malaria vaccines.

Authors:  Bart W Faber; Sumera Younis; Edmond J Remarque; Roberto Rodriguez Garcia; Vanessa Riasat; Vanessa Walraven; Nicole van der Werff; Marjolein van der Eijk; David R Cavanagh; Anthony A Holder; Alan W Thomas; Clemens H M Kocken
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.